These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Obesity, insulin resistance and kidney disease risk: insights into the relationship. Sarafidis PA Curr Opin Nephrol Hypertens; 2008 Sep; 17(5):450-6. PubMed ID: 18695384 [TBL] [Abstract][Full Text] [Related]
3. Microvascular dysfunction in obesity: a potential mechanism in the pathogenesis of obesity-associated insulin resistance and hypertension. Jonk AM; Houben AJ; de Jongh RT; Serné EH; Schaper NC; Stehouwer CD Physiology (Bethesda); 2007 Aug; 22():252-60. PubMed ID: 17699878 [TBL] [Abstract][Full Text] [Related]
4. [Obstructive sleep apnea hypopnea and metabolic syndromes]. Zhang XL Zhonghua Jie He He Hu Xi Za Zhi; 2007 Dec; 30(12):891-3. PubMed ID: 18336762 [No Abstract] [Full Text] [Related]
6. Mechanisms of hypertension in the cardiometabolic syndrome. Redon J; Cifkova R; Laurent S; Nilsson P; Narkiewicz K; Erdine S; Mancia G J Hypertens; 2009 Mar; 27(3):441-51. PubMed ID: 19262221 [TBL] [Abstract][Full Text] [Related]
7. Role of leptin in the cardiovascular and endocrine complications of metabolic syndrome. Correia ML; Rahmouni K Diabetes Obes Metab; 2006 Nov; 8(6):603-10. PubMed ID: 17026484 [TBL] [Abstract][Full Text] [Related]
8. Microvascular dysfunction: causative role in the association between hypertension, insulin resistance and the metabolic syndrome? Serné EH; de Jongh RT; Eringa EC; Ijzerman RG; de Boer MP; Stehouwer CD Essays Biochem; 2006; 42():163-76. PubMed ID: 17144887 [TBL] [Abstract][Full Text] [Related]
9. Hypertension, insulin resistance, and the metabolic syndrome. Natali A; Ferrannini E Endocrinol Metab Clin North Am; 2004 Jun; 33(2):417-29. PubMed ID: 15158527 [TBL] [Abstract][Full Text] [Related]
10. Metabolic syndrome: is it a syndrome? Does it matter? Kahn R Circulation; 2007 Apr; 115(13):1806-10; discussion 1811. PubMed ID: 17404171 [No Abstract] [Full Text] [Related]
12. Prehypertension is associated with insulin resistance state and not with an initial renal function impairment. A Metabolic Syndrome in Active Subjects in Spain (MESYAS) Registry substudy. Cordero A; Laclaustra M; León M; Grima A; Casasnovas JA; Luengo E; del Rio A; Ferreira I; Alegria E Am J Hypertens; 2006 Feb; 19(2):189-96; discussion 197-8. PubMed ID: 16448891 [TBL] [Abstract][Full Text] [Related]
14. Metabolic syndrome and kidney disease. Ritz E Blood Purif; 2008; 26(1):59-62. PubMed ID: 18182798 [TBL] [Abstract][Full Text] [Related]
15. Hypertension in obese patients: a dysmetabolic hypertension with a possible adipocyte dysfunction mechanism. Blaj S; Stanciu S; Jurcut C; Ciobîcă L Rom J Intern Med; 2003; 41(2):103-11. PubMed ID: 15526495 [TBL] [Abstract][Full Text] [Related]
17. The role of obesity and its bioclinical correlates in the progression of chronic kidney disease. Chalmers L; Kaskel FJ; Bamgbola O Adv Chronic Kidney Dis; 2006 Oct; 13(4):352-64. PubMed ID: 17045221 [TBL] [Abstract][Full Text] [Related]
18. Metabolic syndrome: a comprehensive perspective based on interactions between obesity, diabetes, and inflammation. Dandona P; Aljada A; Chaudhuri A; Mohanty P; Garg R Circulation; 2005 Mar; 111(11):1448-54. PubMed ID: 15781756 [No Abstract] [Full Text] [Related]
19. Clinical study of the risk factors of insulin resistance and metabolic syndrome after kidney transplantation. Sui W; Zou H; Zou G; Yan Q; Chen H; Che W; Xie S Transpl Immunol; 2008 Nov; 20(1-2):95-8. PubMed ID: 18703143 [TBL] [Abstract][Full Text] [Related]
20. Nonalcoholic fatty liver disease as a feature of the metabolic syndrome. Socha P; Wierzbicka A; Neuhoff-Murawska J; Włodarek D; Podleśny J; Socha J Rocz Panstw Zakl Hig; 2007; 58(1):129-37. PubMed ID: 17711101 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]